Skip to content

Unraveling cocaine metabolism in patients with cocaine use disorder for the purpose of potentially improving bioanalytical tests for cocaine use

Unraveling cocaine metabolism in patients with cocaine use disorder for the purpose of potentially improving bioanalytical tests for cocaine use - Unraveling cocaine metabolism in patients with CUD

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON56992
Enrollment
10
Registered
2024-09-06
Start date
2024-11-12
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stoornis in het gebruik van cocaïne cocaine addiction Cocaine use disorder

Interventions

None listed

Sponsors

Indigo i-psy PsyQ Brijder B.V.
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: 1. Age between 18 and 65 years of age; 2. Moderate or severe cocaine use disorder according to DSM-5 (>=4 criteria); 3. Active participation in heroine-assisted treatment; 4. Snorting, inhaling or injecting cocaine use as primary route of administration; 5. Able and willing to provide one blood sample; 6. Able and willing to provide urine- and saliva-samples and to be interviewed about recent drug use for 2 times per week during 4 consecutive weeks; 7. Understanding and speaking Dutch; 8. Able and willing to give written informed consent.

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: 1. Does not have a sufficiently good understanding of Dutch for informed consent.

Design outcomes

Primary

MeasureTime frame
To observe the metabolic profile of cocaine in urine, saliva and blood of volunteers with cocaine use disorder participating in heroin-assisted treatment.

Secondary

MeasureTime frame
To explore whether the bioanalytical method for determining cocaine use in patients with cocaine use disorder could be improved by quantitative measurement, measurement of a metabolite other than benzoylecgonine, or measurement in a different biomatrix (saliva).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)